Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFK1W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,837
Award facts
- Contract value 100% obligated
- $28,836.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28.8K delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 6, 2026, for the supply of Dupixent 300 mg/2 mL pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 7, 2026. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99M through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and asthma. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications for military and veteran healthcare systems. The company's federal contract awards demonstrate consistent capability to meet competitive procurement requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles that facilitate efficient pharmaceutical supply chain management.
Quick answers
Who was awarded contract SPE2DR26FFK1W?
SPE2DR26FFK1W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FFK1W worth?
The government has obligated $28,837 on SPE2DR26FFK1W.
Is contract SPE2DR26FFK1W an order under another contract?
Yes. SPE2DR26FFK1W is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFK1W competed?
The extent of competition for SPE2DR26FFK1W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award